Skip to main content

Advertisement

SpringerLink
Log in

The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Fine needle aspiration cytology (FNAC) plays an essential role in the evaluation of thyroid nodules especially for the category of follicular neoplasms (FN) representing 25 % of all thyroid cases including different neoplastic entities. Hence, one of the most promising areas is the application of molecular tests to FNAC. Among them, microRNAs (miRNA),identified as negative (post-transcriptional) gene expression regulators involved in tumor development, are likely to discriminate among FNs. Limited data explored the use of miRNAs on FNAC as well as their role in the malignant risk stratification. We aimed to define whether liquid-based cytology (LBC) is a valid method for miRNA evaluation. From June 2014 to March 2015, we enrolled 27FNs with histological follow-up. In the same reference period, 13 benign nodules (BN) and 20 positive for malignancy (PM) were selected as controls. Histologically, FNs resulted in 14 malignancies (3 papillary thyroid carcinoma-PTC and 11 follicular variant of PTC-FVPC) and 13 follicular adenomas (FA). The 20 PMs included two FVPC, 16 PTC and two medullary thyroid carcinoma (MTC). Five miRNAs (10b, 92a, 221/222 cluster, and 375) were studied on LBC and quantified by real-time PCR. Only miR-375 was over-expressed in the FNs diagnosed as carcinomas and in the PMs. A cut-off of 12 miR-375/U6 relative ratio recognized all BNs and 95 % PMs. Specifically, in each category, FVPCs and PTCs did not show any difference while MTCs had the highest value. miR-375 shows 97.1 % sensitivity, 100 % specificity, 96.3 % negative predictive value (NPV), 100 % positive predictive value (PPV), and 98.3 % diagnostic accuracy. LBC is suitable for miRNAs evaluation. miR-375 resulted over-expressed in all malignant FNs and 95 % PMs. It may represent a valid aid in ruling out BNs and supporting PTCs and/or FVPCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. J.A. Sosa, J.W. Hanna, K.A. Robinson et al., Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery 154, 1420–1426 (2013)

    Article  PubMed  Google Scholar 

  2. C.M. Kiernan, J.T. Broome, C.C. Solozano, The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years. Ann. Surg. Oncol. 21, 3522–3527 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  3. S. Ali, Thyroid cytopathology: Bethesda and beyond. Acta Cytol. 55, 4–12 (2011)

    Article  PubMed  Google Scholar 

  4. H.H. Wang, Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn. Cytopathol. 34, 67–76 (2000)

    Article  Google Scholar 

  5. D.N. Poller, A.K. Ibrahim, M.H. Cummings et al., Fine-needle aspiration of the thyroid. Importance of an indeterminate diagnostic category. Cancer Cytopathol. 90, 239–244 (2000)

    Article  CAS  Google Scholar 

  6. G. Fadda, E.D. Rossi, M. Raffaelli et al., Follicular thyroid neoplasms can be classified as low and high risk according to HBME-1 and Galectin 3 expression on liquid based fine needle cytology. Eur. J. Endocrinol. 165, 447–453 (2011)

    Article  CAS  PubMed  Google Scholar 

  7. F. Pagni, M. Prada, P. Goffredo et al., ‘Indeterminate for malignancy’ (TIR3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact. Cytopathol 25, 170–176 (2014)

    Article  CAS  Google Scholar 

  8. J. Diggans, S.Y. Kim, Z. Hu et al., Machine learning from concept to clinic: reliable detection of BRAFV600E DNA mutations in thyroid nodules using high-dimensional RNA expression data. Pac. Symp. Biocomput. 20, 371–382 (2015)

    Google Scholar 

  9. J.F. Krane, P.A. Vanderlaan, W.C. Faquin et al., The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio. Cancer Cytopathol. 120, 111–116 (2012)

    Article  PubMed  Google Scholar 

  10. A.S. Ho, E.E. Sarti, K.S. Jain et al., Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 24, 832–839 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  11. H. Chen, I. Izevbaye, F. Chen et al., Recent advances in follicular variant of papillary thyroid carcinoma. N. Am. J. Med. Sci. 5, 212–216 (2012)

    Article  Google Scholar 

  12. Walts AE, Mirocha JM, Bose S. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status. J. Cancer Res. Clin. Oncol. 141, 1749–1756 (2015). doi:10.1007/s00432-015-1939-9

    Article  CAS  PubMed  Google Scholar 

  13. E.S. Cibas, S.Z. Ali, The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159–1165 (2009)

    Article  PubMed  Google Scholar 

  14. British Thyroid Association, Royal College of Physicians Guidelines for the management of thyroid cancer, 3rd edn. (RCP, London, 2014)

    Google Scholar 

  15. F. Nardi, F. Basolo, A. Crescenzi et al., Italian consensus for the classification and reporting of thyroid cytology. J. Endocrinol. Invest. 37, 593–599 (2014)

    Article  PubMed  Google Scholar 

  16. B.C.G. Freitas, J.M. Cerutti, Genetic markers differentiating follicular thyroid carcinoma from benign lesions. Mol. Cell. Endocrinol. 321, 77–85 (2010)

    Article  CAS  PubMed  Google Scholar 

  17. H.G. Correia-Rodrigues, A.A. Nogueira De Pontes, L.F.F. Adan, Use of molecular markers in samples obtained from preoperative aspiration of thyroid. Endocr. J. 59, 417–424 (2012)

    Article  Google Scholar 

  18. M.N. Nikiforova, Y. Nikiforov, Molecular diagnostics and predictors in thyroid cancer. Thyroid 19, 1351–1361 (2009)

    Article  CAS  PubMed  Google Scholar 

  19. G. Fadda, E.D. Rossi, Liquid based cytology in fine needle aspiration biopsies of the thyroid gland. Acta Cytol. 55, 389–400 (2011)

    Article  CAS  PubMed  Google Scholar 

  20. D. Dabbs, C.S. Abendroth, R.T. Grenko et al., Immunocytochemistry on the Thin-prep processor. Diagn. Cytopathol. 17, 388–392 (1997)

    Article  CAS  PubMed  Google Scholar 

  21. A. Longatto-Filho, A.E. Goncalves, O. Martinho et al., Liquid based cytology in DNA-based molecular research. Anal. Quant. Cytol. Histol. 31, 395–400 (2009)

    Google Scholar 

  22. E.D. Rossi, M. Martini, S. Capodimonti et al., Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. Eur. J. Endocrinol. 168, 853–859 (2013)

    Article  CAS  PubMed  Google Scholar 

  23. Y.E. Nikiforov, D.L. Steward, T.M. Robinson-Smith et al., Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J. Clin. Endocrinol. Metab. 94, 2092–2098 (2009)

    Article  CAS  PubMed  Google Scholar 

  24. H. Mazeh, I. Mizrahi, D. Halle et al., Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples. Thyroid 21, 111–118 (2011)

    Article  CAS  PubMed  Google Scholar 

  25. R. Shen, S. Liyanarachchi, W. Li et al., MicroRNA signature in thyroid fine needle aspiration cytology applied to “atipia of undetermined significance” cases. Thyroid 22, 9–16 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. M.N. Nikiforova, S.I. Chiosea, Y.E. Nikiforov, MicroRNA expression profiles in thyroid microRNAs in thryoid fine needle aspiration biopsy samples. Thyroid 22, 285–291 (2012)

    Article  CAS  Google Scholar 

  27. M.N. Nikiforova, G.C. Tseng, D. Steward et al., MicroRNA expression profiling of thyroid tumors: biological significance and diagnistic utility. J. Clin. Endocrinol. Metab. 93, 1600–1608 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. H. Mazeh, Y. Levy, I. Mizrahi et al., Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy. J. Surg. Res. 180, 216–221 (2013)

    Article  CAS  PubMed  Google Scholar 

  29. X.M. Keutgen, F. Filicori, M.J. Crowley et al., A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin. Cancer Res. 18, 2032–2038 (2012)

    Article  CAS  PubMed  Google Scholar 

  30. P. Pallante, R. Visone, M. Ferracin et al., MircoRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer 13, 497–508 (2006)

    Article  CAS  PubMed  Google Scholar 

  31. F. Weber, R.E. Teresi, C.E. Broelsch et al., A limited set of human microRNA is deregulated in follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 91, 3584–3591 (2006)

    Article  CAS  PubMed  Google Scholar 

  32. M.T. Tetzlaff, A. Liu, X. Xu, S.R. Master et al., Differential Expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr. Pathol. 18, 163–173 (2007)

    Article  CAS  PubMed  Google Scholar 

  33. Y.T. Chen, N. Kitabayashi, X.K. Zhou et al., MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod. Pathol. 21, 1139–1146 (2008)

    Article  CAS  PubMed  Google Scholar 

  34. S.Y. Sheu, F. Grabellus, S. Schwertheim et al., Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumors. Br. J. Cancer 102, 376–382 (2010)

    Article  CAS  PubMed  Google Scholar 

  35. Y. Peng, C. Li, D.C. Luo et al., Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. Molecules 19, 11586–11599 (2014)

    Article  CAS  PubMed  Google Scholar 

  36. C.K. Chou, R.F. Chen, F.F. Chou et al., miR-146 is highly expressed in adult papillary thyroid carcinoma with high risk features including extrathyroidal invasion and the BRAF (V600E) mutation. Thyroid 20, 489–494 (2010)

    Article  CAS  PubMed  Google Scholar 

  37. L. Yip, L. Kelly, Y. Shuai et al., MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann. Surg. Oncol. 18, 2035–2041 (2011)

    Article  PubMed  Google Scholar 

  38. J. Hudson, E. Duncavage, A. Tamburrino et al., Over expression of miR-10a and miR-375 and down regulation of YAP1 in medullary thyroid carcinoma. Exp. Mol. Pathol. 95, 62–67 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. J.W. Yan, J.S. Lin, X.X. He, The emerging role of miR-375 in cancer. Int. J. Cancer 135, 1011–1018 (2013)

    Article  CAS  PubMed  Google Scholar 

  40. T. Jikuzono, M. Kawamoto, H. Yoshitake et al., The miR-221/222 custer, miR-10B and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma. Int. J. Oncol. 42, 1858–1868 (2013)

    CAS  PubMed  PubMed Central  Google Scholar 

  41. P. Agretti, E. Ferrarini, T. Rago et al., MicroRNA expression profile help to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine needle aspiration. Eur. J. Endocrinol. 167, 393–400 (2012)

    Article  CAS  PubMed  Google Scholar 

  42. Y. Zhang, Q. Zhong, X. Chen et al., Diagnostic value of microRNAs in discriminating malignant thyroid nodules from benign ones on fine needle aspiration samples. Tumor Biol. 35, 9343–9353 (2014)

    Article  CAS  Google Scholar 

  43. M. Dettmer, A. Perren, H. Moch et al., Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 23, 1383–1389 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. M. Dettmer, A. Vogetseder, M.B. Durso et al., MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas. J. Clin. Endocrinol. Metab. 98, E1–E7 (2013)

    Article  CAS  PubMed  Google Scholar 

  45. American Joint Commission on Cancer (AJCC) Cancer Staging Atlas, 2nd edn. (2013)

  46. M. Xing, BRAF mutationin papillary thyroid cancer: pathogenic role, molecular bases and clinical implications. Endocr. Rev. 28, 742–762 (2007)

    Article  CAS  PubMed  Google Scholar 

  47. T.H. Kim, Y.J. Park, J.A. Lim et al., The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer. Cancer 118, 1764–1773 (2012)

    Article  CAS  PubMed  Google Scholar 

  48. M. Drage, B. Howitt, J. Krane, J. Barletta et al., Fine needle aspiration diagnoses of non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma. Mod. Pathol. 28, S-134A (2015)

    Google Scholar 

Download references

Acknowledgments

The authors thank Mrs. Elisabeth Boyle for the invaluable support with the English language.

Funding

This research did not receive any specific grant from any funding agency in the public, commercial, or not-profit sectors.

Author information

Authors and Affiliations

  1. Division of Anatomic Pathology and Histology, “Agostino Gemelli” School of Medicine, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, Rome, Italy

    Esther Diana Rossi, Tommaso Bizzarro, Maurizio Martini, Sara Capodimonti, Diletta Sarti, Tonia Cenci, Mirna Bilotta, Guido Fadda & Luigi Maria Larocca

Authors
  1. Esther Diana Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tommaso Bizzarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurizio Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sara Capodimonti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Diletta Sarti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tonia Cenci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mirna Bilotta
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Guido Fadda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Luigi Maria Larocca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esther Diana Rossi.

Ethics declarations

Conflict of interest

The authors have no conflict of interests

Additional information

The abstract was prized as the best oral presentation during the 39th European congress of cytology held in Milan September 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossi, E.D., Bizzarro, T., Martini, M. et al. The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms. Endocrine 54, 723–732 (2016). https://doi.org/10.1007/s12020-016-0866-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-016-0866-0

Keywords

Search

Navigation